aA total of 136 patients did not start DCVAC/PCa (119 because of production failures and 19 for other reasons).
bBecause of a protocol violation, 4 patients in the placebo group received DCVAC/PCa; these 4 patients were included in the DCVAC/PCa group in the safety analysis set.
AE indicates adverse event; ICF, informed consent form.